Monitoring PD-L1 Expression on Circulating Tumor-Associated Cells in Recurrent Metastatic Non-Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation Therapy.

JCO Precis Oncol · 2022 · PMC10166406 · PMID 36516370

Europe PMC DOI

hedged sentences

0.0021

closest p · 0.0× alpha

0.0716

boldest claim

The sentences

highly significantP = .0021actually significant

In the no ICI group, only sex was highly significant for better PFS in female patients ( P = .0021), and none of the variables were significant for OS (Table 3 ).

also in 132,142 other papers

borderline significantP = .0716so close (0.05 < p ≤ 0.1)

The patients who increased TAC PD-L1 expression showed significantly improved survival with ICI treatments over 24 months for PFS (HR, 3.49; 95% CI, 1.5 to 8.3; P = .0091) and borderline significant OS (HR, 2.61; 95% CI, 1.0 to 6.6; P = .0716).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.